Barrett's esophagus: Diagnosis, follow-up and treatment

Danish Medical Journal

Volumn 59, Issue 8, 2012, Pages

  Bremholm, Lasse ^a   Funch Jensen, Peter ^a   Eriksen, Jan ^a   Hendel, Lene ^a   Havelund, Troels ^a   Matzen, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; DISEASE SEVERITY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; FOLLOW UP; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; RISK FACTOR; SCREENING;

EID: 84873257459     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011 Oct 13;365(15):1375-83.
2. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008 Aug 1;168(3):237-49.
3. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011 Jul 6;103(13):1049-57.
4. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008 Mar;103(3):788-97.
5. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006 Nov;131(5):1392-9.
6. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003 Feb 4;138(3):176-86.
7. Watson A HRSNA. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. 2012. British Society of Gastroenterology 2005. http://www.bsg.org.uk.
8. Horwhat JD, Maydonovitch CL, Ramos F, Colina R, Gaertner E, Lee H, et al. A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus. Am J Gastroenterol 2008 Mar;103(3):546-54.
9. Kara MA, Peters FP, Rosmolen WD, Krishnadath KK, Ten Kate FJ, Fockens P, et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 2005 Oct;37(10):929-36.
10. Lim CH, Rotimi O, Dexter SP, Axon AT. Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Bar-rett's esophagus. Gastrointest Endosc 2006 Aug;64(2):195-9.
11. Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. BMJ 1998 Apr 18;316(7139):1232-5.